Regulatory Innovation in Postmarketing Risk Assessment and Management

E-ISSN： 1532-6535|91|3|555-557

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.91, Iss.3, 2012-03, pp. : 555-557

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk assessment and management in mental health nursing

By Reynolds Lisa

Health, Risk & Society, Vol. 13, Iss. 6, 2011-09 ,pp. : 599-600

Routledge Ltd

Access to resources Recommend Favorite

Risk in Dementia – Assessment and Management: a Literature Review

By Thom Karen M Blair Sheena E E

The British Journal of Occupational Therapy, Vol. 61, Iss. 10, 1998-10 ,pp. : 441-447

College of Occupational Therapists

Access to resources Recommend Favorite

Strategic management of innovation risk in the biopharmaceutical industry: a UK perspective

By Chandrasekar C.R. Helliar C.V. Lonie A.A. Nixon W.A. Power D.M.

International Journal of Healthcare Technology and Management, Vol. 1, Iss. 1-2, 2003-06 ,pp. : 62-76

Inderscience Publishers

Access to resources Recommend Favorite

Pediatric post‐marketing safety systems in North America: assessment of the current status

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 8, 2015-08 ,pp. : 785-792

John Wiley & Sons Inc

Access to resources Recommend Favorite

Measurement of Low‐Density Lipoprotein Cholesterol in Assessment and Management of Cardiovascular Disease Risk

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 1, 2014-07 ,pp. : 20-22

John Wiley & Sons Inc

Access to resources Recommend Favorite